What is the current Price Target for the Sensei Biotherapeutics Inc stock?

The average Sensei Biotherapeutics Inc target price is $51.00. This is 82.14% higher than the current stock price. The highest price target is 106.25%, the lowest is 80.36%. 5 Analysts have issued a price target Sensei Biotherapeutics Inc 2027 .

How high will the Sensei Biotherapeutics Inc stock rise?

No reliable answer can be given as to how high the Sensei Biotherapeutics Inc stock will rise. The performance of stocks, including the Sensei Biotherapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Sensei Biotherapeutics Inc stock today?

The performance of Sensei Biotherapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Sensei Biotherapeutics Inc stock fall?

The decline in Sensei Biotherapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Sensei Biotherapeutics Inc Forecast, price target & analysts

$28.00

3.61%

Nasdaq, Fri, Sep 25 2026.

ISIN

US81728A1088

Symbol

SNSE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Sensei Biotherapeutics Inc Target price 2026 - Analyst rating & recommendation

Sensei Biotherapeutics Inc Classifications & Recommendation

Buy

80%

Hold

20%

Sensei Biotherapeutics Inc Price Target

Target Price	$51.00
Price	$28.00
Potential	82.14% register free of charge
Number of Estimates	5

	5 Analysts have issued a price target Sensei Biotherapeutics Inc 2027 . The average Sensei Biotherapeutics Inc target price is $51.00. This is 82.14% register free of charge higher than the current stock price. The highest price target is $57.75 106.25% register free of charge , the lowest is $50.50 80.36% register free of charge .
	A rating was issued by 10 analysts: 8 Analysts recommend Sensei Biotherapeutics Inc to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Sensei Biotherapeutics Inc stock has an average upside potential 2027 of 82.14% register free of charge . Most analysts recommend the Sensei Biotherapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-16.72	-6.27
	30.36%	62.50%
P/E		negative

6 Analysts have issued a Sensei Biotherapeutics Inc forecast for earnings per share. The average Sensei Biotherapeutics Inc EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-16.72	30.36%
2026	$-6.27 62.50% unlock
2027	$-8.11 29.35% unlock
2028	$-6.71 17.26% unlock

Current	-0.20	53.53%
2026	-4.46 2,168.57% unlock
2027	-3.45 22.65% unlock
2028	-4.18 21.16% unlock

Sensei Biotherapeutics Inc...

Current Sensei Biotherapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
BTIG	Locked ➜ Locked	Locked	Jun 15 2026
BTIG	Locked ➜ Locked	Locked	Jun 11 2026
Cantor Fitzgerald	Locked ➜ Locked	Locked	May 29 2026
LUCID CAPITAL MARKETS	Locked ➜ Locked	Locked	May 28 2026
Citigroup	Locked ➜ Locked	Locked	May 22 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 30 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 05 2025

Analyst Rating	Date
Locked BTIG: Locked ➜ Locked	Jun 15 2026
Locked BTIG: Locked ➜ Locked	Jun 11 2026
Locked Cantor Fitzgerald: Locked ➜ Locked	May 29 2026
Locked LUCID CAPITAL MARKETS: Locked ➜ Locked	May 28 2026
Locked Citigroup: Locked ➜ Locked	May 22 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 30 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 05 2025

Discover more stocks with a high price target

NIO ADR 104.57%

Alibaba Group Holding Ltd 71.25%

Rheinmetall 66.12%

Infineon 62.78%

Tencent Holdings Ltd. 55.39%

Adyen 53.79%

TUI 52.57%

Uber Technologies 47.97%

BYD 47.84%

Siemens Energy 46.63%

Adidas 42.38%

Deutsche Telekom 37.89%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now